<?xml version="1.0" encoding="UTF-8"?>
<p>According to the COVID-19 drug interactions study developed by Liverpool University, both heparin and argatroban are not susceptible to determine interactions with the investigational anti-COVID-19 agents (RDV, LPV/r, CQ, and HCQ) [
 <xref rid="B80-jcm-09-02084" ref-type="bibr">80</xref>].
</p>
